尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Tyndall Mark Anthony. Director active across 2 companies, notably Mallinckrodt plc. Aggregated, 5 disclosures have been recorded. Activity tracked since 14 December 2022. The latest transaction was disclosed on 14 November 2023 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Tyndall Mark Anthony is a declarant linked to Mallinckrodt plc and Keenova Therapeutics plc. The data block shows 5 filings in total, with the recent sampled filings spanning from 2022-12-22 to 2026-01-05, and the modal transaction nature is option exercise.